Voltz R, Hohlfeld R
Department of Neurology, Klinikum Grosshadern, University of Munich, Germany.
Curr Opin Neurol. 1996 Oct;9(5):360-6. doi: 10.1097/00019052-199610000-00008.
Intravenous immunoglobulin is increasingly used in the treatment of neuromuscular disorders. Its efficacy has been proven in Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and Lambert-Eaton myasthenic syndrome. In addition, there is increasing evidence that it has beneficial effects in other neuromuscular disorders.
